These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1426765)

  • 41. Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites.
    López-Talavera JC; Levitzki A; Martínez M; Gazit A; Esteban R; Guardia J
    J Clin Invest; 1997 Aug; 100(3):664-70. PubMed ID: 9239414
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression profiles of protein tyrosine kinase genes in human embryonic stem cells.
    Son MY; Kim J; Han HW; Woo SM; Cho YS; Kang YK; Han YM
    Reproduction; 2008 Oct; 136(4):423-32. PubMed ID: 18583472
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Benzylidenemalononitrile compounds as activators of cell resistance to oxidative stress and modulators of multiple signaling pathways. A structure-activity relationship study.
    Turpaev K; Ermolenko M; Cresteil T; Drapier JC
    Biochem Pharmacol; 2011 Sep; 82(5):535-47. PubMed ID: 21669191
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibitors of epidermal growth factor receptor kinase and of cyclin-dependent kinase 2 activation induce growth arrest, differentiation, and apoptosis of human papilloma virus 16-immortalized human keratinocytes.
    Ben-Bassat H; Rosenbaum-Mitrani S; Hartzstark Z; Shlomai Z; Kleinberger-Doron N; Gazit A; Plowman G; Levitzki R; Tsvieli R; Levitzki A
    Cancer Res; 1997 Sep; 57(17):3741-50. PubMed ID: 9288782
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vivo pharmacology and anti-tumour evaluation of the tyrphostin tyrosine kinase inhibitor RG13022.
    McLeod HL; Brunton VG; Eckardt N; Lear MJ; Robins DJ; Workman P; Graham MA
    Br J Cancer; 1996 Dec; 74(11):1714-8. PubMed ID: 8956783
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and antiproliferative activity of tyrphostins containing quinoline moieties.
    Brunton VG; Lear MJ; McKeown P; Robins DJ; Workman P
    Anticancer Drug Des; 1996 Sep; 11(6):463-83. PubMed ID: 8836111
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of pancreatic cancer cell growth in vitro by the tyrphostin group of tyrosine kinase inhibitors.
    Gillespie J; Dye JF; Schachter M; Guillou PJ
    Br J Cancer; 1993 Dec; 68(6):1122-6. PubMed ID: 8260363
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor.
    Meydan N; Grunberger T; Dadi H; Shahar M; Arpaia E; Lapidot Z; Leeder JS; Freedman M; Cohen A; Gazit A; Levitzki A; Roifman CM
    Nature; 1996 Feb; 379(6566):645-8. PubMed ID: 8628398
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Specificity of alpha-cyano-beta-hydroxy-beta-methyl-n-[4-(trifluoromethoxy)phe nyl]-propenamide as an inhibitor of the epidermal growth factor receptor tyrosine kinase.
    Ghosh S; Zheng Y; Jun X; Mahajan S; Mao C; Sudbeck EA; Uckun FM
    Clin Cancer Res; 1999 Dec; 5(12):4264-72. PubMed ID: 10632369
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tyrosine phosphorylation in contraction of opossum esophageal longitudinal muscle in response to SNP.
    Hirano I; Kakkar R; Saha JK; Szymanski PT; Goyal RK
    Am J Physiol; 1997 Jul; 273(1 Pt 1):G247-52. PubMed ID: 9252532
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protein binding modulates inhibition of the epidermal growth factor receptor kinase and DNA synthesis by tyrphostins.
    Hoffman R; Dennis IF; Donaldson J
    Cancer Chemother Pharmacol; 1995; 36(4):316-24. PubMed ID: 7628051
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidermal growth factor-specific protein tyrosine phosphorylation in preimplantation embryo development.
    Paria BC; Tsukamura H; Dey SK
    Biol Reprod; 1991 Nov; 45(5):711-8. PubMed ID: 1721842
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cinnamamide analogs as inhibitors of protein tyrosine kinases.
    Buzzetti F; Brasca MG; Crugnola A; Fustinoni S; Longo A; Penco S; Dalla Zonca P; Comoglio PM
    Farmaco; 1993 May; 48(5):615-36. PubMed ID: 8343210
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tyrphostin AG 1478 preferentially inhibits human glioma cells expressing truncated rather than wild-type epidermal growth factor receptors.
    Han Y; Caday CG; Nanda A; Cavenee WK; Huang HJ
    Cancer Res; 1996 Sep; 56(17):3859-61. PubMed ID: 8752145
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protein tyrosine phosphorylation mediates TNF-induced endothelial-neutrophil adhesion in vitro.
    Kelly SA; Goldschmidt-Clermont PJ; Milliken EE; Arai T; Smith EH; Bulkley GB
    Am J Physiol; 1998 Feb; 274(2):H513-9. PubMed ID: 9486255
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhancement of chemosensitivity by tyrphostin AG825 in high-p185(neu) expressing non-small cell lung cancer cells.
    Tsai CM; Levitzki A; Wu LH; Chang KT; Cheng CC; Gazit A; Perng RP
    Cancer Res; 1996 Mar; 56(5):1068-74. PubMed ID: 8640763
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Growth inhibition of human lung adenocarcinoma cells by antibodies against epidermal growth factor receptor and by ganglioside GM3: involvement of receptor-directed protein tyrosine phosphatase(s).
    Suarez Pestana E; Greiser U; Sánchez B; Fernández LE; Lage A; Perez R; Böhmer FD
    Br J Cancer; 1997; 75(2):213-20. PubMed ID: 9010029
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tyrphostins--potential antiproliferative agents and novel molecular tools.
    Levitzki A
    Biochem Pharmacol; 1990 Sep; 40(5):913-8. PubMed ID: 2143901
    [No Abstract]   [Full Text] [Related]  

  • 59. Tyrosine kinase blockers: new platelet activation inhibitors.
    Rendu F; Eldor A; Grelac F; Levy-Toledano S; Levitzki A
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):713-6. PubMed ID: 2133252
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of tyrphostins on the activated c-src protein in NIH/3T3 cells.
    Agbotounou WK; Levitzki A; Jacquemin-Sablon A; Pierre J
    Mol Pharmacol; 1994 May; 45(5):922-31. PubMed ID: 7514714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.